Joanne L. Intile

432 total citations
15 papers, 275 citations indexed

About

Joanne L. Intile is a scholar working on Pulmonary and Respiratory Medicine, Small Animals and Microbiology. According to data from OpenAlex, Joanne L. Intile has authored 15 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 8 papers in Small Animals and 5 papers in Microbiology. Recurrent topics in Joanne L. Intile's work include Veterinary Oncology Research (13 papers), Infectious Diseases and Mycology (8 papers) and Microbial infections and disease research (5 papers). Joanne L. Intile is often cited by papers focused on Veterinary Oncology Research (13 papers), Infectious Diseases and Mycology (8 papers) and Microbial infections and disease research (5 papers). Joanne L. Intile collaborates with scholars based in United States, Canada and Germany. Joanne L. Intile's co-authors include Kenneth M. Rassnick, Dennis B. Bailey, Andrea B. Flory, Michael A. Kiselow, Cheryl E. Balkman, David Russell, Yi Zhou, Michael N. Nitabach, Todd C. Holmes and I. J. Thompson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Veterinary Medical Association and Journal of Veterinary Internal Medicine.

In The Last Decade

Joanne L. Intile

15 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanne L. Intile United States 8 210 152 58 54 50 15 275
J. D. Ferracone United States 5 191 0.9× 102 0.7× 65 1.1× 40 0.7× 16 0.3× 6 284
Yuki Nemoto Japan 10 150 0.7× 21 0.1× 93 1.6× 76 1.4× 96 1.9× 37 321
Ruth Klein Germany 10 63 0.3× 84 0.6× 47 0.8× 128 2.4× 85 1.7× 15 334
Amy M. Knollinger United States 8 61 0.3× 36 0.2× 28 0.5× 40 0.7× 2 0.0× 16 288
Franck Chanut France 9 18 0.1× 36 0.2× 58 1.0× 69 1.3× 21 0.4× 13 174
Carl R. Dragwa United States 6 130 0.6× 8 0.1× 25 0.4× 80 1.5× 205 4.1× 7 447
Jayanta Chakrabarti India 8 16 0.1× 9 0.1× 31 0.5× 36 0.7× 12 0.2× 25 196
Dorothy I. Vollum United Kingdom 13 20 0.1× 26 0.2× 40 0.7× 28 0.5× 25 0.5× 22 367
G Shuttleworth United Kingdom 5 13 0.1× 21 0.1× 56 1.0× 104 1.9× 29 0.6× 7 297
Kye-Yong Song South Korea 11 28 0.1× 29 0.2× 13 0.2× 55 1.0× 6 0.1× 15 324

Countries citing papers authored by Joanne L. Intile

Since Specialization
Citations

This map shows the geographic impact of Joanne L. Intile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne L. Intile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne L. Intile more than expected).

Fields of papers citing papers by Joanne L. Intile

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne L. Intile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne L. Intile. The network helps show where Joanne L. Intile may publish in the future.

Co-authorship network of co-authors of Joanne L. Intile

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne L. Intile. A scholar is included among the top collaborators of Joanne L. Intile based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne L. Intile. Joanne L. Intile is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Marks, Steven L., et al.. (2022). Discharge summaries provided to owners of pets newly diagnosed with cancer exceed recommended readability levels. Journal of the American Veterinary Medical Association. 260(6). 657–661. 2 indexed citations
2.
Berlato, Davide, Craig A. Clifford, Laura D. Garrett, et al.. (2021). Value, Limitations, and Recommendations for Grading of Canine Cutaneous Mast Cell Tumors: A Consensus of the Oncology-Pathology Working Group. Veterinary Pathology. 58(5). 858–863. 25 indexed citations
3.
Fogle, Callie, Joanne L. Intile, & M. Katie Sheats. (2021). Veterinary Clinical Ethics and Patient Care Dilemmas. Veterinary Clinics of North America Small Animal Practice. 51(5). 1079–1097. 3 indexed citations
4.
Intile, Joanne L., et al.. (2021). Lymphoid leukemia in five bearded dragons (Pogona vitticeps). Journal of the American Veterinary Medical Association. 258(7). 748–757. 3 indexed citations
5.
Rassnick, Kenneth M., Dennis B. Bailey, Debra A. Kamstock, et al.. (2021). Survival time for dogs with previously untreated, peripheral nodal, intermediate- or large-cell lymphoma treated with prednisone alone: the Canine Lymphoma Steroid Only trial. Journal of the American Veterinary Medical Association. 259(1). 62–71. 4 indexed citations
6.
Intile, Joanne L., Kenneth M. Rassnick, Renée Al-Sarraf, & John D. Chretin. (2019). Evaluation of the Tolerability of Combination Chemotherapy with Mitoxantrone and Dacarbazine in Dogs with Lymphoma. Journal of the American Animal Hospital Association. 55(2). 101–109. 3 indexed citations
7.
Thamm, Douglas H., Anne C. Avery, Davide Berlato, et al.. (2019). Prognostic and predictive significance of KIT protein expression and c‐kit gene mutation in canine cutaneous mast cell tumours: A consensus of the Oncology‐Pathology Working Group. Veterinary and Comparative Oncology. 17(4). 451–455. 21 indexed citations
9.
Rassnick, Kenneth M., et al.. (2014). Tolerability of Lomustine in Combination with Cyclophosphamide in Dogs with Lymphoma. Journal of the American Animal Hospital Association. 50(3). 167–173. 7 indexed citations
10.
Rassnick, Kenneth M., Dennis B. Bailey, David Russell, et al.. (2010). A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours. Veterinary and Comparative Oncology. 8(2). 138–152. 35 indexed citations
11.
Rassnick, Kenneth M., Antony S. Moore, David Russell, et al.. (2010). Phase II, Open-Label Trial of Single-Agent CCNU in Dogs with Previously Untreated Histiocytic Sarcoma. Journal of Veterinary Internal Medicine. 24(6). 1528–1531. 55 indexed citations
12.
Rassnick, Kenneth M., Dennis B. Bailey, Joanne L. Intile, et al.. (2010). Comparison between l-CHOP and an l-CHOP protocol with interposed treatments of CCNU and MOPP (l-CHOP-CCNU-MOPP) for lymphoma in dogs. Veterinary and Comparative Oncology. 8(4). 243–253. 32 indexed citations
13.
Intile, Joanne L., Kenneth M. Rassnick, Dennis B. Bailey, et al.. (2009). Evaluation of dexamethasone as a chemoprotectant for CCNU‐induced bone marrow suppression in dogs*. Veterinary and Comparative Oncology. 7(1). 69–77. 7 indexed citations
14.
Rassnick, Kenneth M., Dennis B. Bailey, Andrea B. Flory, et al.. (2008). Efficacy of Vinblastine for Treatment of Canine Mast Cell Tumors. Journal of Veterinary Internal Medicine. 22(6). 1390–1396. 34 indexed citations
15.
Nitabach, Michael N., Ricardo C. Araneda, Joanne L. Intile, et al.. (2001). A mechanism for combinatorial regulation of electrical activity: Potassium channel subunits capable of functioning as Src homology 3-dependent adaptors. Proceedings of the National Academy of Sciences. 98(2). 705–710. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026